Freedom Broker Maintains Viemed Healthcare at Hold, Lowers Price Target
Freedom Broker has maintained its 'Hold' rating on Viemed Healthcare, Inc. while reducing the price target from $11 to $10.
Stocks · News reference
Viemed Healthcare, Inc. reported record net revenue of $80.7 million for the third quarter of 2026, representing a 12.2% increase year-over-year.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Freedom Broker has maintained its 'Hold' rating on Viemed Healthcare, Inc. while reducing the price target from $11 to $10.
Filed: 2026-11-04 AccNo: 0001729149-26-000055 Size: 6 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Viemed Healthcare, Inc. has scheduled its third quarter 2026 earnings conference call for November 5, 2026, at 11:00 a.m. EST.
U.S. stock futures fell, with Nasdaq 100 futures down 500 points. Corning dropped 8% after a $2B offering; several other stocks also slid premarket.
Barrington Research initiates coverage on Viemed Healthcare (NASDAQ:VMD) with a Outperform rating and announces Price Target of $14.